Nurse Practitioner in Warsaw, IL Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Katherine Anne Phillips, APRN-FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1102 N County Road 700, Warsaw, IL 62379 Phone: 217-256-4100 Fax: 217-256-3800 |
Teresa Metzger, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1102 N County Road 700, Warsaw, IL 62379 Phone: 217-256-4100 Fax: 217-256-3800 |
News Archive
Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA
Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.
Sigma-Aldrich acquires Molecular Medicine BioServices
Sigma-Aldrich Corporation has announced that it has acquired Molecular Medicine BioServices Inc. (MMB), a biopharmaceutical contract manufacturing organization (CMO) located in Carlsbad, California, to further enhance the biologics capabilities within its SAFC Pharma business segment.
Canadian Diabetes Association releases Saskatchewan Diabetes Cost Model report
Today, the Canadian Diabetes Association released the findings from its Saskatchewan Diabetes Cost Model, indicating that Saskatchewan currently faces the highest combined prevalence of diabetes and prediabetes in the Prairies. The model shows that without action, the cost and prevalence of diabetes in the province will continue to increase substantially over the next 10 years.
Study shows how air pollution makes COVID-19 mortality worse for marginalized populations
As scientists worldwide race to gather data about the novel coronavirus, one of the more surprising findings has been detecting the virus attached to fine particles of air pollution.
EMD Serono's L-BLP25 Phase III NSCLC trial does not meet primary endpoint
EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the Phase III STARTa trial of its investigational product L-BLP25 (formerly referred to as Stimuvax) in patients with unresectable, locally advanced stage IIIA or IIIB non-small cell lung cancer (NSCLC) did not meet its primary endpoint to demonstrate a statistically significant improvement in overall survival (OS).
› Verified 8 days ago